title: Patient Selection for Neoadjuvant Therapy in Early-Stage Pancreatic Cancer.
authors.affiliation: John R. Bergquist, Christopher R. Shubert, Curtis B. Storlie, Elizabeth B. Habermann, and Mark J. Truty, Mayo Clinic, Rochester, MN.
authors.forename: John R
authors.initials: JR
authors.lastname: Bergquist
authors.affiliation: John R. Bergquist, Christopher R. Shubert, Curtis B. Storlie, Elizabeth B. Habermann, and Mark J. Truty, Mayo Clinic, Rochester, MN.
authors.forename: Christopher R
authors.initials: CR
authors.lastname: Shubert
authors.affiliation: John R. Bergquist, Christopher R. Shubert, Curtis B. Storlie, Elizabeth B. Habermann, and Mark J. Truty, Mayo Clinic, Rochester, MN.
authors.forename: Curtis B
authors.initials: CB
authors.lastname: Storlie
authors.affiliation: John R. Bergquist, Christopher R. Shubert, Curtis B. Storlie, Elizabeth B. Habermann, and Mark J. Truty, Mayo Clinic, Rochester, MN.
authors.forename: Elizabeth B
authors.initials: EB
authors.lastname: Habermann
authors.affiliation: John R. Bergquist, Christopher R. Shubert, Curtis B. Storlie, Elizabeth B. Habermann, and Mark J. Truty, Mayo Clinic, Rochester, MN.
authors.forename: Mark J
authors.initials: MJ
authors.lastname: Truty
mesh_terms: D006801:Humans; D020360:Neoadjuvant Therapy; D010179:Pancreas; D010190:Pancreatic Neoplasms; D018579:Patient Selection; D057216:Propensity Score